NEW YORK, Sept. 08, 2016 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Envision Healthcare Holdings, Inc. (“Envision Healthcare” or the “Company”) (NYSE:EVHC) in the United States District Court for the District of Colorado on behalf of current stock holders of Envision Healthcare, seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”).
This action stems from a proposed transaction announced on June 15, 2016, pursuant to which Envision Healthcare will be acquired by AmSurg Corp. (“Parent”) through Parent’s wholly-owned subsidiary, New Amethyst Corp. (“Merger Sub,” and together with Parent, “AmSurg”). On June 15, 2016, the Board caused Envision to enter into an agreement and plan of merger (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, AmSurg will acquire all of the outstanding shares of Envision common stock for 0.334 AmSurg shares per Envision share, in a transaction valued at approximately $4.73 billion. The Complaint alleges that the Form S-4 Registration Statement omits material information with respect to the proposed transaction, which renders the Form S-4 Registration Statement false and misleading.
If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



